Sort
17,054 grants matching “genome editing”
Project 2 - Type I Diabetes Project
$173,301David V. Serreze · Jackson Laboratory · U54 · FY2018 · OD
Microfluidic platforms to generate 'off-the-shelf' fratricide-resistant CAR T cells for T-cell malignancies
$173,201Sunil Sudhir Raikar · Emory University · R21 · FY2022 · CA
Mechanisms and vulnerabilities of ERG-driven luminal fate in prostate cancer
$173,016Weiran Feng · Sloan-Kettering Inst Can Research · K99 · FY2024 · CA
Mechanisms and vulnerabilities of ERG-driven luminal fate in prostate cancer
$173,016Weiran Feng · Sloan-Kettering Inst Can Research · K99 · FY2023 · CA
Project 2 - Type I Diabetes Project
$172,944David V. Serreze · Jackson Laboratory · U54 · FY2019 · OD
Using bacterial CRISPR/Cas endonucleases to selectively eliminate HPV-transformed cells in vivo
$172,913Bryan R. Cullen · Duke University · R21 · FY2016 · CA
Discovery of Novel Genetic Variants in Congenital Heart Disease by Whole Genome Sequencing
$172,800Jason George Homsy · Brigham And Women'S Hospital · K08 · FY2017 · HL
New computational, transcriptional, and genome editing approaches to the biology of inflammatory bowel disease
$172,745Gregory C. Gibson · Georgia Institute Of Technology · R01 · FY2021 · DK
Genome Editing of Stem Cells for Analysis of Osteoarthritis Causal Variants
$172,700Farshid Guilak · Duke University · R21 · FY2014 · AR
Dissection of the transcriptional network of human primordial germ cells
$172,630Renee A Reijo Pera · California Poly State U San Luis Obispo · R01 · FY2019 · HD
CRISPR Core
$172,542Matthew John Hart · University Of Oklahoma Hlth Sciences Ctr · P30 · FY2025 · AG
Intravesical genome editing in urothelium
$172,500Xue-Ru Wu · New York University School Of Medicine · R21 · FY2025 · DK
Genotypic Interactions in Brain Cancer Heterogeneity
$172,498Frank Furnari · Ludwig Institute For Cancer Res Ltd · R01 · FY2020 · NS
Role of the DREAM complex in the lung tumor suppression
$172,376Larisa Litovchick · Virginia Commonwealth University · R21 · FY2024 · CA
Novel inhibitors of oncogenic p53 mutants for lung cancer therapy.
$172,376Swati P Deb · Virginia Commonwealth University · R21 · FY2024 · CA
In vivo detection of 2-hydroxyglutarate in gliomas by spectroscopic MRI
$172,369Changho Choi · Ut Southwestern Medical Center · R21 · FY2011 · CA
From association to function at the PHACTR1 GWAS locus for coronary atherosclerosis
$172,320Rajat M Gupta · Massachusetts General Hospital · K08 · FY2018 · HL
From association to function at the PHACTR1 GWAS locus for coronary atherosclerosis
$172,320Rajat M Gupta · Massachusetts General Hospital · K08 · FY2016 · HL
From association to function at the PHACTR1 GWAS locus for coronary atherosclerosis
$172,320Rajat M Gupta · Massachusetts General Hospital · K08 · FY2017 · HL
A Transgenic Rat for Noninvasive Assessment of Chondrogenic Activity in vivo
$172,222Ryan Michael Porter · Beth Israel Deaconess Medical Center · R21 · FY2017 · AR
Mechanisms of intestinal epithelial injury in intestinal inflammation
$172,098Michael George Kattah · University Of California, San Francisco · K08 · FY2020 · DK
Mechanisms of intestinal epithelial injury in intestinal inflammation
$172,098Michael George Kattah · University Of California, San Francisco · K08 · FY2021 · DK
Genome editing for the correction of Pompe disease
$172,089Dwight D Koeberl · Duke University · R21 · FY2020 · AR
Admin-Core-001
$172,073Timothy P Cripe · Research Inst Nationwide Children'S Hosp · U54 · FY2022 · CA
Diversity Supplement: Hernandez-Aguirre- Cripe U54
$172,073Timothy P Cripe · Research Inst Nationwide Children'S Hosp · U54 · FY2022 · CA